To PFKFB3 or Not to PFKFB3, That Is the Question

Cristina Branco, Randall S. Johnson

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)


In this issue of Cancer Cell, Cantelmo et al. describe how reduction of PFKFB3 enzyme activity can promote vascular normalization. The authors show in turn how this affects vascular permeability and can ultimately improve the efficacy of chemotherapeutic agents.
Original languageEnglish
Pages (from-to)831
Number of pages1
JournalCancer Cell
Issue number6
Publication statusPublished - 12 Dec 2016


Dive into the research topics of 'To PFKFB3 or Not to PFKFB3, That Is the Question'. Together they form a unique fingerprint.

Cite this